nach oben

Acta Neurologica Belgica

Erschienen in:

29.05.2023 | Original article

Initial frontal lobe involvement in adult cerebral X-linked adrenoleukodystrophy

verfasst von: Wei Jiang, Wei Jin, Hulin Zhao, Dehui Huang, Lei Wu

Erschienen in: Acta Neurologica Belgica | Ausgabe 6/2023

Einloggen, um Zugang zu erhalten

Abstract

Objective

Adult cerebral X-linked adrenoleukodystrophy (ACALD) with initial frontal lobe involvement is a rare genetic disease that is easily misdiagnosed and underdiagnosed. We sought to improve the early identification of such diseases.

Methods

We present three cases of adult X-linked adrenoleukodystrophy (ALD) with initial frontal lobe involvement and identify an additional 13 cases from the database. The clinical and imaging characteristics of the overall sixteen cases were analyzed.

Results

The average age of onset was 37 years, with 15 male and 1 female patient. A total of 12 patients (75%) developed a decline in cerebral executive and cognitive functions. Brain trauma is the possible trigger for the onset of ALD in five patients (31%). An elevated level of very-long-chain fatty acids (VLCFA) was observed in all 15 patients on whom a plasma VLCFA was performed.10 patients with gene tests showed different mutation sites in the ABCD1 gene. Brain MRI of six patients (46%) were characterized by frontal lobe “butterfly wings"-like lesions with peripheral rim enhancement. Four patients underwent brain biopsies (patients 1, 3, 15, and 13), and five patients (31%) were initially misdiagnosed (patients 1, 2, 3, 11, and 15). Nine of the patients with follow-up records experienced poor prognoses, and five of them, unfortunately, died (56%).

Conclusion

ACALD patients with anterior patterns tend to be misdiagnosed. The early clinical manifestation is a decline in cerebral executive and cognitive function. Brain trauma may be a trigger for this pattern. Brain MRI findings are characterized by frontal lobe “butterfly wing”-like lesions with peripheral rim enhancement. The determination of the VLCFA levels and the genetic detection of the causative mutations are required to confirm the diagnosis.

Wiesinger C, Eichler FS, Berger J (2015) The genetic landscape of X-linked adrenoleukodystrophy: inheritance, mutations, modifier genes, and diagnosis. Appl Clin Genet 8:109–121. https://doi.org/10.2147/tacg.S49590CrossRefPubMedPubMedCentral

Moser HW, Mahmood A, Raymond GV (2007) X-linked adrenoleukodystrophy. Nat Clin Pract Neurol 3:140–151. https://doi.org/10.1038/ncpneuro0421CrossRefPubMed

Moser HW (1995) Komrower lecture. adrenoleukodystrophy: natural history, treatment and outcome. J Inherit Metab Dis 18:435–447. https://doi.org/10.1007/bf00710055CrossRefPubMed

Mao C, Li J, Huang X, Wang J, Chu S, Zhang Y, Dong L, Liu C, Lu L, Qiu L, Chen W, Peng B, Cui L, Gao J (2022) Typical and atypical phenotype and neuroimaging of X-linked adrenoleukodystrophy in a Chinese cohort. Neurol Sci: Official J Ital Neurol Soc Ital Soc Clin Neurophysiol 43:3255–3263. https://doi.org/10.1007/s10072-021-05859-yCrossRef

Moser HW, Loes DJ, Melhem ER, Raymond GV, Bezman L, Cox CS, Lu SE (2000) X-Linked adrenoleukodystrophy: overview and prognosis as a function of age and brain magnetic resonance imaging abnormality. A study involving 372 patients. Neuropediatrics 31:227–239. https://doi.org/10.1055/s-2000-9236CrossRefPubMed

Afifi AK, Menezes AH, Reed LA, Bell WE (1996) Atypical presentation of X-linked childhood adrenoleukodystrophy with an unusual magnetic resonance imaging pattern. J Child Neurol 11:497–499. https://doi.org/10.1177/088307389601100620CrossRefPubMed

Loes DJ, Fatemi A, Melhem ER, Gupte N, Bezman L, Moser HW, Raymond GV (2003) Analysis of MRI patterns aids prediction of progression in X-linked adrenoleukodystrophy. Neurology 61:369–374. https://doi.org/10.1212/01.Wnl.0000079050.91337.83CrossRefPubMed

Schönfeld P, Reiser G (2021) How the brain fights fatty acids’ toxicity. Neurochem Int 148:105050. https://doi.org/10.1016/j.neuint.2021.105050CrossRefPubMed

Woodcock T, Morganti-Kossmann MC (2013) The role of markers of inflammation in traumatic brain injury. Front Neurol 4:18. https://doi.org/10.3389/fneur.2013.00018CrossRefPubMedPubMedCentral

10.

Liu C, Cao Y, Bu B (2019) Teaching neuroimages: frontal lobe involvement in adult-onset cerebral X-linked adrenoleukodystrophy. Neurology 93:e1326–e1327. https://doi.org/10.1212/wnl.0000000000008181CrossRefPubMed

11.

Inoue S, Terada S, Matsumoto T, Ujike H, Uchitomi Y (2012) A case of adult-onset adrenoleukodystrophy with frontal lobe dysfunction: a novel point mutation in the ABCD1 gene. Int Med (Tokyo, Japan) 51:1403–1406. https://doi.org/10.2169/internalmedicine.51.6899CrossRef

12.

Kemp S, Berger J, Aubourg P (2012) X-linked adrenoleukodystrophy: clinical, metabolic, genetic and pathophysiological aspects. Biochem Biophys Acta 1822:1465–1474. https://doi.org/10.1016/j.bbadis.2012.03.012CrossRefPubMed

13.

Chen X, Chen Z, Huang D, Liu X, Gui Q, Yu S (2014) Adult cerebral adrenoleukodystrophy and Addison’s disease in a female carrier. Gene 544:248–251. https://doi.org/10.1016/j.gene.2014.04.056CrossRefPubMed

14.

van der Voorn JP, Pouwels PJ, Powers JM, Kamphorst W, Martin JJ, Troost D, Spreeuwenberg MD, Barkhof F, van der Knaap MS (2011) Correlating quantitative MR imaging with histopathology in X-linked adrenoleukodystrophy. AJNR Am J Neuroradiol 32:481–489. https://doi.org/10.3174/ajnr.A2327CrossRefPubMedPubMedCentral

15.

Sutovský S, Petrovic R, Chandoga J, Turcáni P (2007) Adult onset cerebral form of X-linked adrenoleukodystrophy with dementia of frontal lobe type with new L160P mutation in ABCD1 gene. J Neurol Sci 263:149–153. https://doi.org/10.1016/j.jns.2007.01.082CrossRefPubMed

16.

Mehrpour M, Gohari F, Dizaji MZ, Ahani A, Malicdan MC, Behnam B (2016) An ABCD1 mutation (c.253dupC) caused diverse phenotypes of adrenoleukodystrophy in an iranian consanguineous pedigree. J Mol Genetic Med Int J Biomed Res. https://doi.org/10.4172/1747-1862CrossRef

17.

Sutovský S, Kolníková M, Petrovic R, Kollár B, Siarnik P, Chandoga J, Fischerová M, Turcáni P (2014) Differing clinical presentations of two unrelated cases of X-linked adrenoleukodystrophy with identical mutation Y296C in the ABCD1 gene. Neuro Endocrinol Lett 35:411–416PubMed

18.

Dato C, Capaldo G, Terracciano C, Napolitano F, D’Amico A, Pappatà S, Santorelli FM, Di Iorio G, Sampaolo S, Melone MA (2019) Late adult-onset adrenomyeloneuropathy evolving with atypical severe frontal lobe syndrome: importance of neuroimaging. Radiol Case Rep. 14:309–31410. https://doi.org/10.1016/j.radcr.2018.11.007CrossRefPubMed

19.

Budhram A, Pandey SK (2017) Activation of Cerebral X-linked Adrenoleukodystrophy After Head Trauma. Can J Neurol Sci Le journal canadien des sciences neurologiques 44:597–59810. https://doi.org/10.1017/cjn.2017.52CrossRef

20.

Fellner A, Benninger F, Djaldetti R (2016) Synthetic cannabinoids revealing adrenoleukodystrophy. J Clin Neurosci Off J Neurosurg Soc Aust 24:155–156. https://doi.org/10.1016/j.jocn.2015.07.020CrossRef

21.

Larner AJ (2003) Adult-onset dementia with prominent frontal lobe dysfunction in X-linked adrenoleukodystrophy with R152C mutation in ABCD1 gene. J Neurol 250:1253–1254. https://doi.org/10.1007/s00415-003-0172-7CrossRefPubMed

22.

Ochi H, Yamashita Y (1996) A case of adult type adrenoleukodystrophy with an acute onset and repeated episodes of ataxic dysarthria. Rinsho Shinkeigaku Clin Neurol 36:1229–1233

23.

Maris T, Androulidakis EJ, Tzagournissakis M, Papavassiliou S, Moser H, Plaitakis A (1995) X-linked adrenoleukodystrophy presenting as neurologically pure familial spastic paraparesis. Neurology 45:1101–1104. https://doi.org/10.1212/wnl.45.6.1101CrossRefPubMed

24.

Nagumo K, Shinotoh H, Arai K, Furumoto H, Hirayama K (1995) Frontal type adrenoleukodystrophy: the progress of the white matter lesion–a neuroradiological and pathological study. Rinsho Shinkeigaku Clin Neurol 35:983–990

25.

Bouquet F, Dehais C, Sanson M, Lubetzki C, Louapre C (2015) Dramatic worsening of adult-onset X-linked adrenoleukodystrophy after head trauma. Neurology 85:1991–1993. https://doi.org/10.1212/wnl.0000000000002173CrossRefPubMed

26.

Raymond GV, Seidman R, Monteith TS, Kolodny E, Sathe S, Mahmood A, Powers JM (2010) Head trauma can initiate the onset of adreno-leukodystrophy. J Neurol Sci 290:70–74. https://doi.org/10.1016/j.jns.2009.11.005CrossRefPubMed

Titel: Initial frontal lobe involvement in adult cerebral X-linked adrenoleukodystrophy
verfasst von: Wei Jiang
Wei Jin
Hulin Zhao
Dehui Huang
Lei Wu
Publikationsdatum: 29.05.2023
Verlag: Springer International Publishing
Erschienen in: Acta Neurologica Belgica / Ausgabe 6/2023
Print ISSN: 0300-9009
Elektronische ISSN: 2240-2993
DOI: https://doi.org/10.1007/s13760-023-02295-x

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Neurologie

Nicht Creutzfeldt Jakob, sondern Abführtee-Vergiftung

29.05.2024 Hyponatriämie Nachrichten

Eine ältere Frau trinkt regelmäßig Sennesblättertee gegen ihre Verstopfung. Der scheint plötzlich gut zu wirken. Auf Durchfall und Erbrechen folgt allerdings eine Hyponatriämie. Nach deren Korrektur kommt es plötzlich zu progredienten Kognitions- und Verhaltensstörungen.

Schutz der Synapsen bei Alzheimer

29.05.2024 Morbus Alzheimer Nachrichten

Mit einem Neurotrophin-Rezeptor-Modulator lässt sich möglicherweise eine bestehende Alzheimerdemenz etwas abschwächen: Erste Phase-2-Daten deuten auf einen verbesserten Synapsenschutz.

Sozialer Aufstieg verringert Demenzgefahr

24.05.2024 Demenz Nachrichten

Ein hohes soziales Niveau ist mit die beste Versicherung gegen eine Demenz. Noch geringer ist das Demenzrisiko für Menschen, die sozial aufsteigen: Sie gewinnen fast zwei demenzfreie Lebensjahre. Umgekehrt steigt die Demenzgefahr beim sozialen Abstieg.

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Abstract

Objective

Methods

Results

Conclusion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 6/2023

Effects of specialized nursing intervention based on quantitative assessment strategy on psychological state and quality of life of patients with senile dementia

Phosphodiesterase 4 D (PDE4D) gene polymorphisms and risk of ischemic stroke: A systematic review and meta-analysis

Correction to: RBD and hyposmia in Moroccan patients with a synucleinopathy: prevalence and the timing of occurrence in a large cohort

Serum cystatin C is correlated with mortality of traumatic brain injury patients partially mediated by acute kidney injury

Predictors of unprovoked seizures in intracerebral hemorrhages